Vincent de Caprio
Director/Miembro de la Junta en New Jersey Institute of Technology .
Perfil
Vincent de Caprio was President and Chief Executive Officer of Vyteris Holdings, Inc. He joined Vyteris Holdings, Inc. in 2000.
He is a Fellow of the American Institute of Medical and Biological Engineering.
He is a Trustee of New Jersey Institute of Technology.
He received a BSEE degree from the Newark College of Engineering in 1972, an MS degree in 1975 from Polytechnic University and a PhD in 1977 from Polytechnic University.
Cargos activos de Vincent de Caprio
Empresas | Cargo | Inicio |
---|---|---|
New Jersey Institute of Technology | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Vincent de Caprio.
Empresas | Cargo | Fin |
---|---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Presidente | 31/12/2005 |
Treasure Mountain Holdings, Inc. | Presidente | 17/05/2005 |
Formación de Vincent de Caprio.
New Jersey Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Treasure Mountain Holdings, Inc. | Producer Manufacturing |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
Polytechnic University | Consumer Services |
- Bolsa de valores
- Insiders
- Vincent de Caprio